Mechanical thrombectomy: can it be safely delivered out of hours in the UK?

BMC Neurology

Table 6 Swift prime trial comparison

	Royal Stoke University Hospital (n = 501)	Swift Prime trial
Total eligible	142	98
Mortality at 90 days	15 (11%)	9 (9%)
Functional independence at 90 days	85 (59%)	59 (60%)

Number of patients eligible for treatment if the Swift-Prime trial inclusion criteria had been applied and outcomes at 90 days. Eligibility of 142 patients was based upon: age > 18 and < 80 (n = 423); NIHSS > 8 and < 30 (n = 422); intravenous tissue plasminogen activator given (n = 368); internal carotid artery or middle cerebral artery segment 1 occlusion (n = 397); onset to procedure end < 6 h (n = 294)

ISSN: 1471-2377